Madrigal Announces Publication in the Journal of Hepatology Demonstrating Consistent Rezdiffra Efficacy Across Common MASH Genetic Risk VariantsGlobeNewsWire · Oct 6, 2026
Genetic discovery yields clues toward reversal of Alzheimer's brain damageReuters · Sep 25, 2026
Armata Pharmaceuticals to Present Data at ISSSI 2026 Showing Defined Genetic Diversity in AP-SA02 May Enhance Killing of Certain Staphylococcus aureus Clinical IsolatesPRNewsWire · Sep 21, 2026
Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing ProgramGlobeNewsWire · Sep 3, 2026
Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing ProgramGlobeNewsWire · Sep 1, 2026
Regeneron Secures FDA Approval for Rare Genetic Disorder DrugZacks Investment Research · Aug 20, 2026Genetic Technologies Limited (GENE) is a molecular diagnostics company specializing in providing predictive testing and assessment tools. These solutions empower healthcare professionals to better manage women's health concerns in both Australia and the United States. Its flagship product, BREVAGenplus, is a clinically validated risk assessment test specifically designed for non-hereditary breast cancer.